Skip to main content
CriticalFDAfda-F-1924-2016CONTAMINATION

Al Rasheed Sardine Item #4017 Label not available - NYSDAM sampling.

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
106
Recall Date
June 20, 2016
Issuing Agency
Hazard
Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1924-2016.

Greenland Trading Corporation is recalling Al Rasheed Sardines due to potential C. botulinum contamination.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1924-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Greenland Trading Corp or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1924-2016.

Greenland Trading Corp

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Greenland Trading Corp Recall FAQ

Greenland Trading Corp is the subject of a food safety report: Al Rasheed Sardine Item #4017 Label not available - NYSDAM sampling.. The notice was published on June 20, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 106 units are potentially affected.